Quadrant Capital Group LLC Kura Oncology, Inc. Transaction History
Quadrant Capital Group LLC
- $1.42 Billion
- Q3 2024
A detailed history of Quadrant Capital Group LLC transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 1,690 shares of KURA stock, worth $27,868. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,690
Previous 1,697
0.41%
Holding current value
$27,868
Previous $34,000
2.94%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding KURA
# of Institutions
185Shares Held
81.7MCall Options Held
42.1KPut Options Held
34K-
Suvretta Capital Management, LLC New York, NY7.65MShares$126 Million5.88% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$115 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$95.8 Million4.92% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$89.2 Million1.97% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.33MShares$71.4 Million3.05% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.1B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...